Draganfly Inc DPRO 深 沪
已收盘 05-08 16:00:00 美东时间
5.48
+0.260
+4.98%
华盛通- 最 高5.70
- 今 开5.39
- 成交量 202.29万股
- 最 低 5.211
- 昨 收 5.22
- 总市值 2.00亿
- 52周最高 14.40
- 市盈率 静 --
- 换手率 5.54%
- 52周最低 1.63
- 委 比 -89.86%
- 总股本 3649.59万
- 历史最高 104.75
- 量 比 1.79
- 振 幅 9.37%
- 历史最低 1.63
- 每 手 1
- 风险率 2.43%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Draganfly Wins New U.S. Defense Orders for Flex FPV Drones
Draganfly ( ($TSE:DPRO) ) has shared an update. On May 8, 2026, Draganfly Inc.,...
05-09 06:45
Draganfly Selected By Two Separate Pentagon Units For Its Flex FPV Drone Systems
This reflects continued demand for Draganfly's FPV platforms across defense applications where rapidly deployable, adaptable, and mission-ready drone systems are increasingly being used to support training, operational
05-08 20:32
Next-Generation Defense Is Unmanned as Global Drone Industry Targets $160Billion+ Expansion
Military adoption leads the charge as drones become essential tools across intelligence, protection, and combat missions Market News Updates News Commentary NEW YORK, April 16, 2026 /PRNews...
04-16 21:20
Global Counter-UAS Interceptor Market Surges Amid Escalating Drone Warfare Threats
Defense Sector Rushes to Deploy Counter-Drone Interceptors as Threat Landscape Intensifies Market News Updates News Commentary NEW YORK, April 2, 2026 /PRNewswire/ -- Counter-UAS intercepto...
04-02 21:50
3 Small-Cap Drone Stocks to Buy Right Now
Investors can capitalize on the growing drone economy, as seen in the U.S.-Iran war, through small- and mid-cap stocks like ONDS and RCAT, with potential gains of over 100%.
03-31 23:56
美股大行评级 | 潜在涨幅172.14%！Alumis获Oppenheimer上调目标价至55美元；摩根大通首予希捷科技"超配"评级，目标价525美元
今日重点评级关注：Oppenheimer：维持Alumis"跑赢大市"评级，目标价从50美元升至55美元；美银证券：维持Rocket Pharmaceuticals"买入"评级，目标价从8美元升至9美元
03-31 16:30
HC Wainwright & Co. Reiterates Buy on Draganfly, Maintains $14 Price Target
HC Wainwright & Co. analyst Scott Buck reiterates Draganfly (NASDAQ:DPRO) with a Buy and maintains $14 price target.
03-30 18:11
美股大行评级 | 最高240美元，潜在涨幅53%！ARM获多家大行上调目标价；Braze 评级上演 “两极反转”，小摩、巴克莱上调，高盛、花旗下调
今日重点评级关注：HC Wainwright & Co.：维持OCUGEN"买入"评级，目标价从7美元升至10美元；HC Wainwright & Co.：维持Maze Therapeutics"买入"评级，目标价从60美元升至110美元
03-26 11:41
Draganfly Stock Sheds 21% Post-Earnings — Here's Why It's Still A Buy
Shares of drone tech company Draganfly sell off hard after disappointing Q4 earnings. Here's why it's still a buy.
03-26 06:21
Draganfly shares are trading lower after the company reported worse-than-expected Q4 financial results.
Draganfly shares are trading lower after the company reported worse-than-expect...
03-26 00:04
